Lisa Purcell joined Regeneron in 2008 and is a Clinical Scientist in Immunology and Inflammation. She received her PhD from McGill University and completed her Postdoctoral Training at Columbia University. Dr. Purcell’s current work focuses on the clinical development of therapies within the immunology and infectious disease therapeutic areas, including those for SARS-CoV-2/COVID-19. She has also developed therapies for pathogens using Regeneron’s novel technologies. Dr. Purcell was the scientific director of Regeneron’s science education efforts including the Regeneron Science Talent Search, research mentorship efforts, the International and Westchester Science and Engineering Fair and STEM teacher programs. She is currently the Vice President of Vir Biotechnology.

Kurt Edelman is an infectious disease scientist specializing in immunology and virology with 14 years of industry experience at two leading biotech companies (Amgen & Regeneron).

Sokol is a Lab Head in the Immunology and Inflammation group with a broad interest in cellular and molecular mechanisms that ensure optimal immune responses in health and understanding of their dysregulation in autoimmune disease. His work focuses on preclinical modeling of human disease, deep profiling of the immunological players and disease mechanisms with the goal of identifying and validating novel therapeutic options to address unmet medical needs.

Anna Zumsteg has been with Regeneron since 2014 and was a Senior Staff Scientist in the Infectious Diseases therapeutic focus area. During her PhD at Stanford University and Postdoctoral Training at the Max Planck Institute for Infection Biology, she explored concepts in host-pathogen interactions critical for disease. At Regeneron, her work focused on applying that understanding to design new approaches to more effectively treat bacterial infections. She is currently the Director at Vir Biotechnology.